David Medvedeff

organizations such as The Mayo Clinic and Kaiser Permanente to give their patients a voice in the optimization of the care experience - a meaningful component of healthcare reform.

Earlier in his career David was the President of Informed Decisions, a subsidiary of Gold Standard which was acquired by Elsevier Health; the world’s largest medical publisher. His multifaceted role with Elsevier simultaneously included leading the company’s electronic prescribing initiatives, managing the predictive modeling and analytics unit MEDai, as well as serving as the Vice President of payer and provider strategy for the Clinical Decision Support division.

David has been the humble recipient of numerous industry accolades. Some of his more notable honors include being the only two-time winner of the American Pharmacist Association’s Pinnacle Award as well as receiving the prestigious National Prescott Award. David plays an active role in several transformational healthcare organizations. He has chaired the National Changing Diabetes Program Health Information Technology group, The Pharmacy Quality Alliance’s Diabetes and Medication Reconciliation Workgroups and served on the Florida Behavioral Health Collaborative. He currently serves on the Board of Directors of Strata Decision Technology, Pharmacy Quality Solutions and the Executive Board of The Beryl Institute.

David earned his Doctor of Pharmacy and Master of Business Administration from the University of Florida, where he served on the faculty of College of Pharmacy and earned the Outstanding Alumnus and Outstanding Service Excellence awards.